Kirill Zaslavsky, M.D.,Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hemianopsia | 3 | 2021 | 121 | 1.990 |
Why?
|
Optic Atrophy, Hereditary, Leber | 2 | 2021 | 50 | 1.500 |
Why?
|
Nerve Compression Syndromes | 2 | 2021 | 160 | 1.300 |
Why?
|
Retinal Ganglion Cells | 3 | 2023 | 805 | 0.980 |
Why?
|
Eye Infections, Fungal | 1 | 2024 | 100 | 0.840 |
Why?
|
Endophthalmitis | 1 | 2024 | 256 | 0.740 |
Why?
|
Scotoma | 1 | 2021 | 130 | 0.720 |
Why?
|
Hyperbaric Oxygenation | 1 | 2021 | 166 | 0.720 |
Why?
|
Societies, Scientific | 2 | 2018 | 221 | 0.680 |
Why?
|
Choroidal Neovascularization | 1 | 2022 | 357 | 0.650 |
Why?
|
Visual Fields | 2 | 2021 | 1053 | 0.570 |
Why?
|
Vision Disorders | 2 | 2021 | 1081 | 0.560 |
Why?
|
Dendrites | 1 | 2019 | 475 | 0.530 |
Why?
|
Cysts | 1 | 2021 | 684 | 0.520 |
Why?
|
Retinal Diseases | 1 | 2020 | 702 | 0.450 |
Why?
|
Rosacea | 2 | 2024 | 59 | 0.440 |
Why?
|
Congresses as Topic | 1 | 2017 | 804 | 0.410 |
Why?
|
Visual Field Tests | 3 | 2021 | 410 | 0.340 |
Why?
|
Neurons | 8 | 2020 | 9411 | 0.330 |
Why?
|
Societies, Medical | 2 | 2018 | 3890 | 0.320 |
Why?
|
Alcohol Drinking | 1 | 2021 | 4006 | 0.310 |
Why?
|
Biomedical Research | 3 | 2018 | 3416 | 0.290 |
Why?
|
Fluorescein Angiography | 2 | 2022 | 1042 | 0.280 |
Why?
|
Nerve Tissue Proteins | 2 | 2019 | 4409 | 0.270 |
Why?
|
Diabetes Mellitus | 1 | 2024 | 5880 | 0.250 |
Why?
|
Induced Pluripotent Stem Cells | 5 | 2020 | 1845 | 0.240 |
Why?
|
Herpes Zoster Ophthalmicus | 1 | 2023 | 37 | 0.220 |
Why?
|
Ophthalmoplegia | 1 | 2023 | 168 | 0.200 |
Why?
|
Visual Acuity | 2 | 2021 | 2619 | 0.200 |
Why?
|
Keloid | 1 | 2022 | 53 | 0.190 |
Why?
|
Transverse Sinuses | 1 | 2021 | 25 | 0.190 |
Why?
|
Pandemics | 1 | 2021 | 8609 | 0.190 |
Why?
|
Optic Neuritis | 1 | 2023 | 174 | 0.190 |
Why?
|
Cicatrix, Hypertrophic | 1 | 2022 | 80 | 0.180 |
Why?
|
Diplopia | 1 | 2022 | 214 | 0.180 |
Why?
|
Vitrectomy | 1 | 2024 | 388 | 0.180 |
Why?
|
Fundus Oculi | 1 | 2021 | 541 | 0.180 |
Why?
|
Tomography, Optical Coherence | 3 | 2023 | 2873 | 0.180 |
Why?
|
Dentate Gyrus | 2 | 2011 | 163 | 0.170 |
Why?
|
Fistula | 1 | 2021 | 215 | 0.170 |
Why?
|
Pseudotumor Cerebri | 1 | 2021 | 108 | 0.170 |
Why?
|
Retinal Artery Occlusion | 1 | 2020 | 77 | 0.170 |
Why?
|
Dry Eye Syndromes | 1 | 2024 | 386 | 0.170 |
Why?
|
Autistic Disorder | 2 | 2019 | 1213 | 0.170 |
Why?
|
Gene Knockout Techniques | 2 | 2019 | 803 | 0.160 |
Why?
|
Methyl-CpG-Binding Protein 2 | 2 | 2020 | 187 | 0.160 |
Why?
|
Thrombophilia | 1 | 2021 | 307 | 0.160 |
Why?
|
Eye | 1 | 2022 | 709 | 0.160 |
Why?
|
Rett Syndrome | 1 | 2020 | 164 | 0.150 |
Why?
|
Syphilis | 1 | 2021 | 240 | 0.150 |
Why?
|
Cerebrospinal Fluid | 1 | 2021 | 542 | 0.150 |
Why?
|
Canada | 3 | 2018 | 2124 | 0.150 |
Why?
|
Education, Professional | 1 | 2018 | 51 | 0.150 |
Why?
|
Strabismus | 1 | 2022 | 317 | 0.150 |
Why?
|
Excitatory Postsynaptic Potentials | 1 | 2019 | 369 | 0.150 |
Why?
|
Giant Cell Arteritis | 1 | 2021 | 296 | 0.140 |
Why?
|
Multiple Sclerosis, Relapsing-Remitting | 1 | 2023 | 556 | 0.140 |
Why?
|
Haploinsufficiency | 1 | 2019 | 329 | 0.140 |
Why?
|
Ribosomes | 1 | 2020 | 497 | 0.140 |
Why?
|
Nervous System | 1 | 2020 | 543 | 0.140 |
Why?
|
DNA, Mitochondrial | 1 | 2021 | 849 | 0.130 |
Why?
|
Exanthema | 1 | 2021 | 504 | 0.130 |
Why?
|
Nose | 1 | 2020 | 515 | 0.130 |
Why?
|
Cataract Extraction | 1 | 2020 | 465 | 0.130 |
Why?
|
Ubiquitination | 1 | 2020 | 1009 | 0.120 |
Why?
|
Coculture Techniques | 1 | 2019 | 1335 | 0.120 |
Why?
|
Skin Diseases | 1 | 2024 | 1091 | 0.120 |
Why?
|
Neurogenesis | 2 | 2011 | 854 | 0.120 |
Why?
|
Tissue Plasminogen Activator | 1 | 2020 | 1189 | 0.110 |
Why?
|
Humans | 27 | 2024 | 759255 | 0.110 |
Why?
|
Glucocorticoids | 1 | 2023 | 2142 | 0.110 |
Why?
|
Williams Syndrome | 1 | 2015 | 193 | 0.110 |
Why?
|
Entorhinal Cortex | 2 | 2011 | 277 | 0.110 |
Why?
|
Angiogenesis Inhibitors | 1 | 2022 | 2048 | 0.100 |
Why?
|
Neuronal Plasticity | 2 | 2019 | 1428 | 0.100 |
Why?
|
Research Personnel | 1 | 2016 | 582 | 0.100 |
Why?
|
RNA-Binding Proteins | 2 | 2020 | 1902 | 0.100 |
Why?
|
Spatial Behavior | 1 | 2011 | 88 | 0.100 |
Why?
|
Memory | 2 | 2011 | 2179 | 0.090 |
Why?
|
Antiviral Agents | 1 | 2023 | 3060 | 0.090 |
Why?
|
Male | 11 | 2024 | 358719 | 0.080 |
Why?
|
Multiple Sclerosis | 1 | 2023 | 3190 | 0.070 |
Why?
|
Retrospective Studies | 4 | 2024 | 80121 | 0.070 |
Why?
|
3' Untranslated Regions | 2 | 2020 | 522 | 0.070 |
Why?
|
Middle Aged | 4 | 2024 | 219653 | 0.060 |
Why?
|
Magnetic Resonance Imaging | 3 | 2021 | 36160 | 0.060 |
Why?
|
Female | 9 | 2024 | 390240 | 0.060 |
Why?
|
Emulsions | 1 | 2024 | 150 | 0.060 |
Why?
|
Deep Brain Stimulation | 1 | 2011 | 812 | 0.050 |
Why?
|
Atrial Fibrillation | 1 | 2021 | 5198 | 0.050 |
Why?
|
Transcription, Genetic | 1 | 2016 | 7595 | 0.050 |
Why?
|
Triamcinolone | 1 | 2022 | 68 | 0.050 |
Why?
|
Antibodies, Anticardiolipin | 1 | 2021 | 62 | 0.050 |
Why?
|
Lupus Coagulation Inhibitor | 1 | 2021 | 34 | 0.050 |
Why?
|
Antithrombin III | 1 | 2021 | 129 | 0.050 |
Why?
|
Protein C | 1 | 2021 | 133 | 0.050 |
Why?
|
Prothrombin | 1 | 2021 | 191 | 0.050 |
Why?
|
Cyclosporine | 1 | 2024 | 778 | 0.050 |
Why?
|
Silicones | 1 | 2022 | 227 | 0.050 |
Why?
|
Protein Biosynthesis | 2 | 2020 | 2118 | 0.050 |
Why?
|
Vision, Binocular | 1 | 2022 | 224 | 0.040 |
Why?
|
MicroRNAs | 1 | 2016 | 3797 | 0.040 |
Why?
|
Temporal Arteries | 1 | 2021 | 143 | 0.040 |
Why?
|
Models, Biological | 1 | 2015 | 9466 | 0.040 |
Why?
|
Maze Learning | 2 | 2011 | 477 | 0.040 |
Why?
|
Gene Expression Regulation | 1 | 2016 | 11908 | 0.040 |
Why?
|
Nerve Net | 1 | 2010 | 2253 | 0.040 |
Why?
|
Homocysteine | 1 | 2021 | 640 | 0.040 |
Why?
|
Fibrinogen | 1 | 2021 | 887 | 0.040 |
Why?
|
Ribosomal Proteins | 1 | 2020 | 360 | 0.040 |
Why?
|
Atrophy | 1 | 2023 | 1625 | 0.040 |
Why?
|
Constriction, Pathologic | 1 | 2021 | 1101 | 0.040 |
Why?
|
Base Sequence | 2 | 2020 | 12450 | 0.040 |
Why?
|
Adult | 5 | 2023 | 219390 | 0.040 |
Why?
|
Fluorouracil | 1 | 2022 | 1620 | 0.040 |
Why?
|
Mutation | 1 | 2021 | 29877 | 0.030 |
Why?
|
Genetic Predisposition to Disease | 1 | 2018 | 17750 | 0.030 |
Why?
|
RNA, Untranslated | 1 | 2020 | 459 | 0.030 |
Why?
|
Electrodes | 1 | 2018 | 613 | 0.030 |
Why?
|
Hemizygote | 1 | 2015 | 28 | 0.030 |
Why?
|
Protein Binding | 2 | 2020 | 9334 | 0.030 |
Why?
|
Mutagenesis, Insertional | 1 | 2018 | 652 | 0.030 |
Why?
|
Glycolysis | 1 | 2020 | 828 | 0.030 |
Why?
|
Ontario | 1 | 2016 | 404 | 0.030 |
Why?
|
Diagnosis, Differential | 2 | 2021 | 12964 | 0.030 |
Why?
|
Prosencephalon | 1 | 2016 | 304 | 0.030 |
Why?
|
Cell Shape | 1 | 2015 | 372 | 0.030 |
Why?
|
Autoantibodies | 1 | 2023 | 2116 | 0.030 |
Why?
|
RNA Stability | 1 | 2016 | 336 | 0.030 |
Why?
|
Headache | 1 | 2022 | 1249 | 0.030 |
Why?
|
Aged | 3 | 2023 | 168617 | 0.030 |
Why?
|
Conserved Sequence | 1 | 2016 | 1168 | 0.030 |
Why?
|
Drug Therapy, Combination | 1 | 2023 | 6496 | 0.030 |
Why?
|
Potassium Channels | 1 | 2015 | 532 | 0.030 |
Why?
|
Neuroanatomical Tract-Tracing Techniques | 1 | 2011 | 40 | 0.020 |
Why?
|
Universities | 1 | 2016 | 980 | 0.020 |
Why?
|
Pentylenetetrazole | 1 | 2010 | 71 | 0.020 |
Why?
|
Convulsants | 1 | 2010 | 70 | 0.020 |
Why?
|
Genes, fos | 1 | 2010 | 174 | 0.020 |
Why?
|
Fibrinolytic Agents | 1 | 2020 | 2168 | 0.020 |
Why?
|
Synapses | 1 | 2019 | 1748 | 0.020 |
Why?
|
Mice, 129 Strain | 1 | 2010 | 374 | 0.020 |
Why?
|
Biopsy | 1 | 2021 | 6772 | 0.020 |
Why?
|
Crosses, Genetic | 1 | 2010 | 752 | 0.020 |
Why?
|
Phenotype | 2 | 2018 | 16532 | 0.020 |
Why?
|
Internal Medicine | 1 | 2016 | 1045 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2018 | 4262 | 0.020 |
Why?
|
Neural Stem Cells | 1 | 2016 | 884 | 0.020 |
Why?
|
Mice, Inbred Strains | 1 | 2011 | 1766 | 0.020 |
Why?
|
Avoidance Learning | 1 | 2010 | 248 | 0.020 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2020 | 3600 | 0.020 |
Why?
|
Down-Regulation | 1 | 2015 | 2920 | 0.020 |
Why?
|
Action Potentials | 1 | 2015 | 1810 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-fos | 1 | 2010 | 587 | 0.020 |
Why?
|
Conditioning, Classical | 1 | 2010 | 363 | 0.020 |
Why?
|
Cell Lineage | 1 | 2016 | 2524 | 0.020 |
Why?
|
Electric Stimulation | 1 | 2010 | 1736 | 0.020 |
Why?
|
Anti-Bacterial Agents | 1 | 2024 | 7380 | 0.020 |
Why?
|
Cardiology | 1 | 2016 | 1720 | 0.020 |
Why?
|
Cytoskeletal Proteins | 1 | 2010 | 1344 | 0.020 |
Why?
|
Medical Oncology | 1 | 2016 | 2311 | 0.010 |
Why?
|
Education, Medical | 1 | 2016 | 1727 | 0.010 |
Why?
|
Cell Line | 1 | 2018 | 15636 | 0.010 |
Why?
|
Mice | 3 | 2020 | 81138 | 0.010 |
Why?
|
Memory Disorders | 1 | 2010 | 1194 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2019 | 7851 | 0.010 |
Why?
|
Fear | 1 | 2010 | 1461 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2016 | 12774 | 0.010 |
Why?
|
Cell Survival | 1 | 2011 | 5796 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2016 | 10440 | 0.010 |
Why?
|
Neural Pathways | 1 | 2011 | 3039 | 0.010 |
Why?
|
Transcription Factors | 1 | 2020 | 12106 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2015 | 9374 | 0.010 |
Why?
|
Animals | 3 | 2020 | 167838 | 0.010 |
Why?
|
Prospective Studies | 1 | 2023 | 54204 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2015 | 11476 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2023 | 58867 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2020 | 15672 | 0.010 |
Why?
|
Seizures | 1 | 2010 | 2908 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2015 | 20031 | 0.010 |
Why?
|
Apoptosis | 1 | 2011 | 9492 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2022 | 64879 | 0.010 |
Why?
|
Age Factors | 1 | 2010 | 18394 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2010 | 21981 | 0.010 |
Why?
|
Time Factors | 1 | 2011 | 40109 | 0.010 |
Why?
|